{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-006976","form_type":"8-K","ticker":"APRE","cik":"0001781983","company_name":"Aprea Therapeutics, Inc.","filed_at":"2024-01-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.506842+00:00","generated_at":"2026-06-06T16:39:10.145705+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Aprea Therapeutics enters $1.0M at-the-market equity distribution agreement with H.C. Wainwright","bullets":["Enters ATM agreement to sell up to $1.0M of common stock through H.C. Wainwright as agent.","Commission of 3.0% of gross proceeds; net proceeds for general corporate purposes including trials.","Company not obligated to sell any shares; offering made under Form S-3 filed Jan 26, 2024.","At-the-market offering allows stock sales at prevailing market prices over time."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-006976","json":"https://secwatch.observer/filing/0001104659-24-006976.json","markdown":"https://secwatch.observer/filing/0001104659-24-006976.md","text":"https://secwatch.observer/filing/0001104659-24-006976.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1781983/000110465924006976/0001104659-24-006976-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1781983/000110465924006976/tm244107d3_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T16:39:10.145705+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4bad9d62a0fa02ab388c506077a75ae87e6343cb","claim":"Aprea Therapeutics, Inc. entered into Sales Agreement with H.C. Wainwright & Co., LLC valued at up to $1.0 million (effective 2024-01-26).","evidence_excerpt":"On January 26, 2024, Aprea Therapeutics, Inc. (the “Company”) entered into an at the market offering agreement (the “Sales Agreement”) with H.C. Wainwright & Co., LLC (the “HCW”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1781983/000110465924006976/0001104659-24-006976-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"H.C. Wainwright & Co., LLC"},{"label":"Value","value":"up to $1.0 million"},{"label":"Effective","value":"2024-01-26"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}